A Study Comparing the Safety and Tolerability of Two Doses of Fipamezole in Adult Patients With Parkinson's Disease

NCT01149811 · clinicaltrials.gov ↗

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: Fipamezole ODT
DRUG: Fipamezole ODT Cohort 2

Sponsor

Bausch Health Americas, Inc.